BLTE Belite Bio, Inc
Healthcare$137.30-4.82%ClosedMarket Cap: $5.50B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$205.00
Target (Median)
$200.00
Target Range
$187.00 - $223.00
Upside from current price: 49.3%
Rating Distribution
2 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-21 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-03 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-03 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-03-03 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2026-01-28 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-02 | Mizuho | upgrade | Outperform | Neutral |
| 2025-12-01 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-31 | Benchmark | maintain | Buy | Buy |
| 2025-09-15 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $1.15 | $237.8M | 6 |
| Sun Dec 31 | $7.23 | $533.3M | 4 |
| Mon Dec 31 | $15.32 | $1.01B | 2 |
| Tue Dec 31 | $21.03 | $1.44B | 2 |